Unknown

Dataset Information

0

Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes.


ABSTRACT: Aim:To investigate biomarkers for predicting papillary thyroid cancer outcomes. Materials & methods:The expression of biomarkers (ITGA2, SYT12 and CDH3) was studied in a prospective cohort of patients with papillary thyroid cancer. Three outcomes of initial metastases, baseline status and longitudinal status were analyzed and correlated with the biomarkers. Results:SYT12 provided the best prediction of initial metastasis (sensitivity: 72%; specificity: 54%). SYT12 had the highest accuracy for predicting longitudinal status (sensitivity: 100%; specificity: 47%). The best performance for longitudinal status resulted from combining SYT12 with American Thyroid Association risk stratification, with sensitivity and specificity of 88 and 73%, respectively. Conclusion:SYT12 has some prognostic significance in papillary thyroid cancer. Further validation studies in larger populations are warranted.

PROVIDER: S-EPMC5729603 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC5673278 | BioStudies
| S-EPMC7317983 | BioStudies
| S-EPMC6429647 | BioStudies
2019-11-09 | GSE140144 | GEO
| S-EPMC3851831 | BioStudies
| S-EPMC6044525 | BioStudies
| S-EPMC8139519 | BioStudies
| S-EPMC7253736 | BioStudies
| S-EPMC7178523 | BioStudies
| S-EPMC3759451 | BioStudies